Edition:
United Kingdom

Intercept Pharmaceuticals Inc (ICPT.OQ)

ICPT.OQ on NASDAQ Stock Exchange Global Select Market

85.67USD
22 Jun 2018
Change (% chg)

$1.56 (+1.85%)
Prev Close
$84.11
Open
$84.26
Day's High
$85.78
Day's Low
$83.45
Volume
1,547,962
Avg. Vol
249,233
52-wk High
$135.59
52-wk Low
$51.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 35.96 -3.224
FY 2017 Dec '17 37.69 -4.424
Sep '17 41.33 -2.892
Jun '17 30.89 -3.459
Mar '17 21.05 -3.607
FY 2016 Dec '16 13.81 -4.838
Sep '16 5.18 -3.590
Jun '16 5.52 -3.141
Mar '16 0.44 -5.171
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 13 41.23 50.40 37.35 53.00
Quarter Ending Sep-18 13 46.95 52.30 44.51 64.06
Year Ending Dec-18 14 178.04 194.80 172.41 241.08
Year Ending Dec-19 15 270.43 372.40 191.35 430.05
Earnings (per share)
Quarter Ending Jun-18 14 -2.90 -2.61 -3.39 -2.97
Quarter Ending Sep-18 14 -2.70 -2.37 -3.15 -2.54
Year Ending Dec-18 15 -11.41 -10.37 -12.74 -11.71
Year Ending Dec-19 14 -8.84 -7.07 -10.26 -8.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta -2.06 0.91 0.88
Price to Sales (TTM) 24.74 109.18 5.71
Price to Book (MRQ) 10.34 13.44 5.37
Price to Tangible Book (MRQ) 10.34 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 87.57 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 459.55 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago 934.42 77.35 5.68
Sales - 5 Yr. Growth Rate 69.09 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -10.12 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago -10.38 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate 140.73 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 6.61 5.26 2.98
LT Debt to Equity (MRQ) 205.28 24.54 12.19
Total Debt to Equity (MRQ) 205.28 26.17 16.46
Interest Coverage (TTM) -- -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.70 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) -503.88 -- --
EBITD - 5 Yr. Avg -2,241.82 -564.12 10.98
Operating Margin (TTM) -509.75 -706.11 4.74
Operating Margin - 5 Yr. Avg. -2,394.67 -585.15 6.41
Pre-Tax Margin (TTM) -543.36 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -3,082.43 -588.45 6.83
Net Profit Margin (TTM) -543.36 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -3,082.43 -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 155,526 22,312,275 846,855,748
Net Income/Employee (TTM) -845,066 2,947,385 99,619,396
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.12 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.61 -0.70 10.95
Return on Assets - 5 Yr. Avg. -66.63 -0.06 12.32
Return on Investment (TTM) -81.11 2.00 14.38
Return on Investment - 5 Yr. Avg. -72.50 2.81 16.11
Return on Equity (TTM) -131.43 3.49 16.08
Return on Equity - 5 Yr. Avg. -91.12 4.33 17.41
  1 Year 3 Year 5 Year
Sales % 796.87 148.72 69.09
EPS (TTM) % -75.16 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intercept Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -40.20 -42.26 2 53
13 Week -43.72 -46.46 5 69
26 Week -35.69 -40.58 16 77
52 Week -54.46 -61.40 15 48
YTD -35.65 -43.49 19 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.96%
# of Holders: 241
Total Shares Held: 20,105,668
3 Mo. Net Change: 952,850
# New Positions: 24
# Closed Positions: 40
# Increased Positions: 102
# Reduced Positions: 100
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.